These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29557932)

  • 21. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
    Haider SI; Johnell K; Weitoft GR; Thorslund M; Fastbom J
    J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of cytochrome P450-mediated potential drug-drug interactions in residents of intermediate care facilities for older adults in Japan.
    Hamada S; Ohno Y; Kojima T; Ishii S; Okochi J; Akishita M
    Geriatr Gerontol Int; 2019 Jun; 19(6):513-517. PubMed ID: 30912281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study.
    Turner RM; de Koning EM; Fontana V; Thompson A; Pirmohamed M
    BMC Med; 2020 Nov; 18(1):367. PubMed ID: 33234119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prevalence of Polypharmacy and Potential Drug-Drug Interactions among Iranian Cancer Patients: Which Patients were at Risk?
    Bazrafshani MS; Pardakhty A; Kalantari Khandani B; Nasiri N; Moghaderi M; Bazrafshani A; Mehmandoost S; Beigzadeh A; Sharifi H
    Cancer Invest; 2022 May; 40(5):457-472. PubMed ID: 35099344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
    Straubhaar B; Krähenbühl S; Schlienger RG
    Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polypharmacy and the risk of drug-drug interactions and potentially inappropriate medications in hospital psychiatry.
    Wolff J; Hefner G; Normann C; Kaier K; Binder H; Hiemke C; Toto S; Domschke K; Marschollek M; Klimke A
    Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1258-1268. PubMed ID: 34146372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study.
    Rogero-Blanco E; Del-Cura-González I; Aza-Pascual-Salcedo M; García de Blas González F; Terrón-Rodas C; Chimeno-Sánchez S; García-Domingo E; López-Rodríguez JA;
    Eur J Gen Pract; 2021 Dec; 27(1):90-96. PubMed ID: 33982632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria.
    Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO
    Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.
    Pergolizzi JV; Labhsetwar SA; Puenpatom RA; Joo S; Ben-Joseph R; Summers KH
    Pain Pract; 2011; 11(4):325-36. PubMed ID: 21199317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the clinical pharmacist in the prevention of potential drug interactions in geriatric heart failure patients.
    Georgiev KD; Hvarchanova N; Georgieva M; Kanazirev B
    Int J Clin Pharm; 2019 Dec; 41(6):1555-1561. PubMed ID: 31595450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential drug-drug interactions in the medication of medical patients at hospital discharge.
    Egger SS; Drewe J; Schlienger RG
    Eur J Clin Pharmacol; 2003 Mar; 58(11):773-8. PubMed ID: 12634985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of drug-drug interactions in patients whose substance intake was objectively identified by detection in urine.
    Schrecker J; Puet B; Hild C; Schwope DM
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):973-978. PubMed ID: 30092669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence of potential drug-drug interactions in adults with intellectual disability.
    McMahon M; Hatton C; Bowring DL; Hardy C; Preston NJ
    J Intellect Disabil Res; 2021 Oct; 65(10):930-940. PubMed ID: 33988262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study.
    Wright RM; Sloane R; Pieper CF; Ruby-Scelsi C; Twersky J; Schmader KE; Hanlon JT
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):271-80. PubMed ID: 19948303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.
    van Leeuwen RWF; Jansman FGA; van den Bemt PMLA; de Man F; Piran F; Vincenten I; Jager A; Rijneveld AW; Brugma JD; Mathijssen RHJ; van Gelder T
    Ann Oncol; 2015 May; 26(5):992-997. PubMed ID: 25628444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
    Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
    Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug related problems in older adults living with dementia.
    Ruangritchankul S; Peel NM; Hanjani LS; Gray LC
    PLoS One; 2020; 15(7):e0236830. PubMed ID: 32735592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy.
    Cattaneo D; Pasina L; Maggioni AP; Giacomelli A; Oreni L; Covizzi A; Bradanini L; Schiuma M; Antinori S; Ridolfo A; Gervasoni C
    Drugs Aging; 2020 Dec; 37(12):925-933. PubMed ID: 33150470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.
    Viktil KK; Blix HS; Moger TA; Reikvam A
    Br J Clin Pharmacol; 2007 Feb; 63(2):187-95. PubMed ID: 16939529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.
    Nobili A; Licata G; Salerno F; Pasina L; Tettamanti M; Franchi C; De Vittorio L; Marengoni A; Corrao S; Iorio A; Marcucci M; Mannucci PM;
    Eur J Clin Pharmacol; 2011 May; 67(5):507-19. PubMed ID: 21221958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.